Taken together, these data suggested it might be hard to further classify exhausted T cells by combination of differentiated markers CCR7, CD45RA and inhibitory receptors PD-1 and TIGIT in BM of de novo AML patients. The gene discussed is CCR7; the disease is acute myeloid leukemia.